Black Rock Inc. Pa Vmed Inc. Transaction History

Black Rock Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.22 - $0.5 $314 - $714	-1,428 Reduced 0.13%	1,123,775 $337,000
Q2 2023 Aug 11, 2023	SELL	$0.35 - $0.56 $64,434 - $103,096	-184,100 Reduced 14.06%	1,125,203 $461,000
Q1 2023 May 12, 2023	SELL	$0.36 - $0.63 $43,972 - $76,951	-122,146 Reduced 8.53%	1,309,303 $484,000
Q4 2022 Feb 13, 2023	BUY	$0.41 - $18.6 $3,768 - $170,971	9,192 Added 0.65%	1,431,449 $687,000
Q3 2022 Nov 14, 2022	SELL	$0.57 - $34.65 $10,227 - $621,724	-17,943 Reduced 1.25%	1,422,257 $1.22 Million
Q2 2022 Aug 12, 2022	SELL	$0.85 - $1.41 $2.79 Million - $4.62 Million	-3,278,784 Reduced 69.48%	1,440,200 $1.35 Million
Q1 2022 May 12, 2022	SELL	$1.16 - $2.5 $77,933 - $167,960	-67,184 Reduced 1.4%	4,718,984 $6.23 Million
Q4 2021 Feb 10, 2022	BUY	$2.46 - $8.74 $203,319 - $722,361	82,650 Added 1.76%	4,786,168 $11.8 Million
Q3 2021 Nov 09, 2021	BUY	$5.1 - $9.39 $295,060 - $543,258	57,855 Added 1.25%	4,703,518 $40.2 Million
Q2 2021 Aug 11, 2021	BUY	$3.95 - $6.88 $18.4 Million - $32 Million	4,645,663 New	4,645,663 $29.7 Million

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $60.1M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.